A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer. - Fu J; Yan YD; Wan X; Sun XF; Ma XM; Su YJ (Frontiers in pharmacology, 2025)